You have 9 free searches left this month | for more free features.

Condition

Advanced Malignancies (1)

Follicular Lymphoma (1)

NSCLC (1)

Ovarian Cancer (1)

Solid Tumors (1)

Urothelial Cancer (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Dana-Farber Cancer Institute (1)

Pfizer (1)

Collaborator

Pfizer (1)

Intervention

avelumab (2)

pf04518600 (2)

utomilumab (2)

axitinib (1)

cmp 001 (1)

lorlatanib (1)

pemetrexed (1)

rituximab (1)

talazoparib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

pf04518600

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Follicular Lymphoma Trial in United States (Rituximab, Utomilumab, Avelumab)

Active, not recruiting

Follicular Lymphoma

Rituximab
+3 more

Duarte, California
+5 more

Mar 17, 2022

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting

Advanced Malignancies
+4 more

Avelumab
+7 more

Fayetteville, Arkansas
+61 more

Jan 10, 2023